On March 31, 2026, William Blair upgraded 10x Genomics from “Market Perform” to “Outperform,” highlighting its best-in-class genomics platforms and exposure to growing demand for large-scale ...

米国のDNA解析のスタートアップ「10x Genomics」が、新たに3500万ドル（約38億円）のシリーズD資金調達を行った。カリフォルニア州プレザントン本拠の、同社の企業価値は12億8000万ドル（約1400億円）とされた。 10x Genomicsの累計資金調達額は、2億4300万ドルに ...

The completion of the human genome project in 2003 and subsequent refining in 2022 surely signalled the start of a new era in biomedical research. This development assisted us in determining the most ...

The market misinterprets past COVID-era revenue growth for 10x Genomics and fails to integrate current sector growth. Read ...

When producers look to their veterinarians for genomics advice, many may not feel fully confident leading that discussion.

The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how effectively the two are integrated.

The fertility industry in China is using artificial intelligence technology to solve the problem of declining birth rates in ...

Bionano Genomics BNGO just pulled back the curtain on its fourth-quarter results, and the message is clear: the company is ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings ...

Genomics encompasses the study of a complete set of genes, their work process and way of interacting with each other and the environment. There have been several breakthroughs in this field, ...